US Stock MarketDetailed Quotes

NVCT Nuvectis Pharma

Watchlist

6.500
-0.010-0.15%

Close Apr 26 16:00 ET

6.500
0.0000.00%

Post 16:20 ET

115.50MMarket Cap-4545P/E (TTM)

Nuvectis Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-4.34%19.13M

-6.69%22.06M

81.26%24.6M

-7.34%15.47M

248.19%19.99M

247.19%23.64M

88.13%13.57M

--16.69M

-Cash and cash equivalents

-4.34%19.13M

-6.69%22.06M

81.26%24.6M

-7.34%15.47M

248.19%19.99M

247.19%23.64M

88.13%13.57M

--16.69M

Other current assets

-85.68%59K

-83.44%203K

-48.80%341K

-20.00%740K

352.75%412K

--1.23M

--666K

--925K

Total current assets

-5.98%19.19M

-10.47%22.26M

75.17%24.94M

-8.00%16.21M

249.82%20.41M

265.19%24.87M

97.37%14.24M

--17.62M

Non current assets

Non current deferred assets

----

--0

Total non current assets

--0

Total assets

-5.98%19.19M

-10.47%22.26M

75.17%24.94M

-8.00%16.21M

206.52%20.41M

265.19%24.87M

97.37%14.24M

--17.62M

Liabilities

Current liabilities

Payables

-17.53%2.77M

20.79%3.49M

24.06%2.2M

-7.67%2.1M

78.53%3.36M

484.04%2.89M

356.30%1.78M

--2.27M

-accounts payable

-4.78%2.77M

55.13%3.49M

25.73%1.8M

55.37%2.1M

175.05%2.91M

354.75%2.25M

268.64%1.43M

--1.35M

-Other payable

----

17.01%399K

----

-45.39%450K

--640K

--341K

--921K

Current accrued expenses

-6.74%415K

-78.59%158K

-27.72%571K

-77.62%156K

12.66%445K

--738K

--790K

--697K

Current liabilities

12.90%6.98M

24.13%5.58M

68.33%4.61M

28.60%3.93M

155.73%6.19M

807.47%4.49M

603.86%2.74M

--3.06M

Non current liabilities

Preferred securities outside stock equity

----

--0

Total non current liabilities

--0

Total liabilities

12.90%6.98M

24.13%5.58M

68.33%4.61M

28.60%3.93M

-64.98%6.19M

-71.46%4.49M

-76.43%2.74M

--3.06M

Shareholders'equity

Share capital

--0

-common stock

--0

Retained earnings

-69.60%-54.25M

-88.32%-47.62M

-115.03%-41.74M

-127.44%-36.03M

-147.95%-31.99M

-137.70%-25.29M

-225.10%-19.41M

---15.84M

Paid-in capital

43.81%66.45M

40.83%64.31M

100.81%62.07M

58.90%48.31M

2,342.07%46.2M

2,575.04%45.66M

1,867.66%30.91M

--30.4M

Total stockholders'equity

-14.19%12.2M

-18.10%16.69M

76.80%20.33M

-15.69%12.27M

229.17%14.22M

328.10%20.37M

361.36%11.5M

--14.56M

Total equity

-14.19%12.2M

-18.10%16.69M

76.80%20.33M

-15.69%12.27M

229.17%14.22M

328.10%20.37M

361.36%11.5M

--14.56M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-4.34%19.13M	-4.34%19.13M	-6.69%22.06M	81.26%24.6M	-7.34%15.47M	248.19%19.99M	248.19%19.99M	247.19%23.64M	88.13%13.57M	--16.69M
-Cash and cash equivalents	-4.34%19.13M	-4.34%19.13M	-6.69%22.06M	81.26%24.6M	-7.34%15.47M	248.19%19.99M	248.19%19.99M	247.19%23.64M	88.13%13.57M	--16.69M
Other current assets	-85.68%59K	-85.68%59K	-83.44%203K	-48.80%341K	-20.00%740K	352.75%412K	352.75%412K	--1.23M	--666K	--925K
Total current assets	-5.98%19.19M	-5.98%19.19M	-10.47%22.26M	75.17%24.94M	-8.00%16.21M	249.82%20.41M	249.82%20.41M	265.19%24.87M	97.37%14.24M	--17.62M
Non current assets
Non current deferred assets	----	----	----	----	----	----	----	--0	--0	--0
Total non current assets	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total assets	-5.98%19.19M	-5.98%19.19M	-10.47%22.26M	75.17%24.94M	-8.00%16.21M	206.52%20.41M	206.52%20.41M	265.19%24.87M	97.37%14.24M	--17.62M
Liabilities
Current liabilities
Payables	-17.53%2.77M	-17.53%2.77M	20.79%3.49M	24.06%2.2M	-7.67%2.1M	78.53%3.36M	78.53%3.36M	484.04%2.89M	356.30%1.78M	--2.27M
-accounts payable	-4.78%2.77M	-4.78%2.77M	55.13%3.49M	25.73%1.8M	55.37%2.1M	175.05%2.91M	175.05%2.91M	354.75%2.25M	268.64%1.43M	--1.35M
-Other payable	----	----	----	17.01%399K	----	-45.39%450K	-45.39%450K	--640K	--341K	--921K
Current accrued expenses	-6.74%415K	-6.74%415K	-78.59%158K	-27.72%571K	-77.62%156K	12.66%445K	12.66%445K	--738K	--790K	--697K
Current liabilities	12.90%6.98M	12.90%6.98M	24.13%5.58M	68.33%4.61M	28.60%3.93M	155.73%6.19M	155.73%6.19M	807.47%4.49M	603.86%2.74M	--3.06M
Non current liabilities
Preferred securities outside stock equity	----	----	----	----	----	----	----	--0	--0	--0
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	12.90%6.98M	12.90%6.98M	24.13%5.58M	68.33%4.61M	28.60%3.93M	-64.98%6.19M	-64.98%6.19M	-71.46%4.49M	-76.43%2.74M	--3.06M
Shareholders'equity
Share capital	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
-common stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-69.60%-54.25M	-69.60%-54.25M	-88.32%-47.62M	-115.03%-41.74M	-127.44%-36.03M	-147.95%-31.99M	-147.95%-31.99M	-137.70%-25.29M	-225.10%-19.41M	---15.84M
Paid-in capital	43.81%66.45M	43.81%66.45M	40.83%64.31M	100.81%62.07M	58.90%48.31M	2,342.07%46.2M	2,342.07%46.2M	2,575.04%45.66M	1,867.66%30.91M	--30.4M
Total stockholders'equity	-14.19%12.2M	-14.19%12.2M	-18.10%16.69M	76.80%20.33M	-15.69%12.27M	229.17%14.22M	229.17%14.22M	328.10%20.37M	361.36%11.5M	--14.56M
Total equity	-14.19%12.2M	-14.19%12.2M	-18.10%16.69M	76.80%20.33M	-15.69%12.27M	229.17%14.22M	229.17%14.22M	328.10%20.37M	361.36%11.5M	--14.56M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall